Smaller point-of-care systems transforming U.S. flow cytometry market

April 14, 2008, Dublin, Ireland--A new report from Research and Markets finds that high-throughput, miniature, more-robust flow cytometry instruments with multiple applications in both research and clinical environments is stimulating growth in this market sector.

April 14, 2008, Dublin, Ireland--A new report from Research and Markets finds that high-throughput, miniature, and more-robust flow cytometry instruments with multiple applications is stimulating growth in both research and clinical environments.

"U.S. Flow Cytometry Markets", a Frost & Sullivan research service, provides revenue forecasts for the overall market, with detailed market and technology trends. The research service also provides in-depth analysis of market-wide and segment-specific drivers, restraints, and challenges, with the corresponding strategic recommendations.

According to the report, high-throughput, miniature, and more robust flow cytometry instruments with multiple applications to meet the needs of both research and clinical sectors are the order of the day. This will attract more non-users into the end-user fold and drive the short-term growth of the market. For long-term growth, market participants will have to develop next-generation, integrated, point-of-care, and miniature systems.

Companies can benefit greatly by focusing on integrating complementary technologies such as imaging and multiplexing and developing microfluidics-based miniature systems, says the analyst of this research. They should also invest heavily in developing automated systems with improved workflow in terms of sample processing and analysis, and the ability to establish rapid exchange of data across the systems. Once these technologies are ready for commercial launches, they are expected to revolutionize the market.

Despite the availability of such advanced cytometers, end users still perceive them as complicated, expensive, and high on maintenance and operational costs. This lack of end-user awareness of the smaller and better systems has greatly hampered the wide adoption of cytometers.

Therefore, participants should disseminate information about the utility and cost effectiveness of their products through webcasts and electronic newsletters. These methods will help them demonstrate the advantages of the software and technical capabilities of their instruments even in non-traditional applications such as cell biology and protein analysis. Developing new and affordable instruments will also help market entrants establish their credibility among the lower tiers of end users. They can also offer physical demonstrations at various conferences, trade shows, and laboratories to drive home their marketing message.

Maintenance funding is another crucial aspect that needs to be addressed by market participants, since flow cytometers, being complex systems, will require technical support and services for the entire duration of their lifetime. Market participants can take advantage of this scenario by distinguishing themselves through quality and cost-effective repair and support services. Manufacturers should develop multiple, customized, and cost-effective service programs without compromising quality assurances such as full onsite service contracts, laser-only service coverage, preventive maintenance, and equipment validation to satisfy all types of end users, remarks the analyst.

For more information visit

More in Biomedicine